These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32213442)

  • 1. Health state utilities for metastatic breast cancer in Taiwan.
    Chou TC; Chiang SC; Ko Y
    Breast; 2020 Jun; 51():57-64. PubMed ID: 32213442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
    Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
    J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-of-life valuations of advanced breast cancer by New Zealand women.
    Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
    Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
    Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
    Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient preferences for diabetes-related complications in Taiwan.
    Lin YJ; Wang CY; Cheng SW; Ko Y
    Curr Med Res Opin; 2019 Jan; 35(1):7-13. PubMed ID: 29701487
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valuation of pemphigus vulgaris and pemphigus foliaceus health states: a convenience sample experiment.
    Rencz F; Brodszky V; Stalmeier PF; Tamási B; Kárpáti S; Péntek M; Baji P; Mitev AZ; Gulácsi L
    Br J Dermatol; 2016 Sep; 175(3):593-9. PubMed ID: 27062497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preference weights for chemotherapy side effects from the perspective of women with breast cancer.
    Kuchuk I; Bouganim N; Beusterien K; Grinspan J; Vandermeer L; Gertler S; Dent SF; Song X; Segal R; Mazzarello S; Crawley F; Dranitsaris G; Clemons M
    Breast Cancer Res Treat; 2013 Nov; 142(1):101-7. PubMed ID: 24129976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health state utilities associated with attributes of treatments for hepatitis C.
    Matza LS; Sapra SJ; Dillon JF; Kalsekar A; Davies EW; Devine MK; Jordan JB; Landrian AS; Feeny DH
    Eur J Health Econ; 2015 Dec; 16(9):1005-18. PubMed ID: 25481796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elicitation of utility scores in Canada for immune thrombocytopenia treated with romiplostim or watch and rescue.
    Iskedjian M; Tinmouth AT; Arnold DM; Deuson R; Isitt JJ; Mikhael J
    J Med Econ; 2012; 15(2):313-31. PubMed ID: 22136485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off method.
    König HH; Günther OH; Angermeyer MC; Roick C
    Pharmacoeconomics; 2009; 27(5):405-19. PubMed ID: 19586078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuing Treatments for Parkinson Disease Incorporating Process Utility: Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue Scales.
    Weernink MG; Groothuis-Oudshoorn CG; IJzerman MJ; van Til JA
    Value Health; 2016; 19(2):226-32. PubMed ID: 27021757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom.
    Guest JF; Nanuwa K; Barden R
    Health Qual Life Outcomes; 2014 Jun; 12():89. PubMed ID: 24917331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elicitation of health state utilities associated with differing durations of morning stiffness in rheumatoid arthritis.
    Iqbal I; Dasgupta B; Taylor P; Heron L; Pilling C
    J Med Econ; 2012; 15(6):1192-200. PubMed ID: 22804691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
    Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
    J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain quality of life as measured by utilities.
    Wetherington S; Delong L; Kini S; Veledar E; Schaufele MK; McKenzie-Brown AM; Chen SC
    Pain Med; 2014 May; 15(5):865-70. PubMed ID: 24716656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.
    Havrilesky LJ; Broadwater G; Davis DM; Nolte KC; Barnett JC; Myers ER; Kulasingam S
    Gynecol Oncol; 2009 May; 113(2):216-20. PubMed ID: 19217148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health.
    Lugnér AK; Krabbe PFM
    Expert Rev Pharmacoecon Outcomes Res; 2020 Aug; 20(4):331-342. PubMed ID: 32552002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.